Pentwater Capital Management’s Bioventus BVS Stock Holding History

Pentwater Capital Management’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-33,368	Closed	-$472K	–	217
2021 Q3	$472K	Sell	33,368 -632	-2%	-$9.72K	﹤0.01%	215
2021 Q2	$598K	Sell	34,000 -21,000	-38%	-$338K	﹤0.01%	233
2021 Q1	$840K	Buy	+55,000	New	+$783K	0.01%	239

Other funds holding BVS

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return